Cited by 15ECG Monitoring and AnalysisArtificial Intelligence in HealthcareCardiac pacing and defibrillation studies

Opportunistic Screening for Asymptomatic Left Ventricular Dysfunction With the Use of Electrocardiographic Artificial Intelligence: A Cost-Effectiveness Approach

Liu, Wei-Ting, Hsieh, Ping-Hsuan, Lin, Chin-Sheng, Fang, Wen-Hui, Wang, Chih-Hung, Tsai, Chien-Sung, Hung, Yi-Jen, Hsieh, Chung-Bao +2 more·2024·Canadian Journal of Cardiology

Abstract

Background The burden of asymptomatic left ventricular dysfunction (LVD) is greater than that of heart failure; however, a cost-effective tool for asymptomatic LVD screening has not been well validated. We aimed to prospectively validate an artificial intelligence (AI)-enabled electrocardiography (ECG) algorithm for asymptomatic LVD detection and evaluate its cost-effectiveness for opportunistic screening. Methods In this prospective observational study, patients undergoing ECG at outpatient clinics or health check-ups were enrolled in 2 hospitals in Taiwan. Patients were stratified into LVD (left ventricular ejection fraction ≤ 40%) risk groups according to a previously developed ECG algorithm. The performance of AI-ECG was used to conduct a cost-effectiveness analysis of LVD screening compared with no screening. Incremental cost-effectiveness ratio (ICER) and sensitivity analyses were used to examine the cost-effectiveness and robustness of the results. Results Among the 29,137 patients, the algorithm demonstrated areas under the receiver operating characteristic curves of 0.984 and 0.945 for detecting LVD within 28 days in the 2 hospital cohorts. For patients not initially scheduled for ECG, the algorithm predicted future echocardiograms (high-risk, 46.2%; medium-risk, 31.4%; low-risk, 14.6%) and LVD (high-risk, 26.2%; medium-risk, 3.4%; low-risk, 0.1%) at 12 months. Opportunistic screening with AI-ECG could result in a negative ICER of -$7,439 for patients aged 65 years,…

Integrity signals

Registry

Crossref · 10.1016/j.cjca.2023.11.044

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Current evidence most strongly supports AI-ECG for low-LVEF detection, where pragmatic randomized implementation and early economic data are available.

    “Current evidence most strongly supports low-LVEF detection, where pragmatic randomized implementation and early economic data are available.”
  • In a Taiwanese prospective outpatient study of opportunistic AI-ECG screening for asymptomatic left ventricular dysfunction, the strategy yielded a negative incremental cost-effectiveness ratio of -$7,439 for 65-year-old patients and remained cost-saving across age groups in sensitivity analyses.

    “In a Taiwanese prospective outpatient study of opportunistic AI-ECG screening for asymptomatic left ventricular dysfunction, the strategy yielded a negative incremental cost-effectiveness ratio (ICER) of -$7,439 for 65-year-old patients and remained cost-saving across age groups in sensitivity analyses.17”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Liu, W.-T., Hsieh, P.-H., Lin, C.-S., Fang, W.-H., Wang, C.-H., Tsai, C.-S., Hung, Y.-J., Hsieh, C.-B., Lin, C., & Tsai, D.-J.
Affiliations
  • Tri-Service General Hospital (TW)
  • National Defense Medical Center (TW)
  • Zuoying Armed Forces General Hospital (TW)
  • Fu Jen Catholic University (TW)
Corresponding author
Tsai, Dung-Jang
Venue
Canadian Journal of Cardiology
Publisher
Elsevier BV
Published
2024-07
Volume
40
Issue
7
Pages
1310-1321
ISSN
0828-282X (ISSN-L)
OpenAlex
W4389570818
Cited by
15
References
3
Citations by year
2026: 4 · 2025: 8 · 2024: 3
FWCI
2.95
Type
journal article
Language
en
Open access
closed
Locations
  • Canadian Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Science and Technology Council (NSTC 112-2321-B-016-003, 112-2222-E-030-002-MY2)
  • Tri-Service General Hospital (TSGH-D-113054, C202105049)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › ECG Monitoring and Analysis
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords
asymptomatic left ventricular dysfunction, opportunistic screening, cost-effectiveness, left ventricular ejection fraction, risk stratification, heart failure prevention, incremental cost-effectiveness ratio
MeSH terms
Aged, Algorithms, Artificial Intelligence, Cost-Benefit Analysis, Electrocardiography, Female, Humans, Male, Mass Screening, Middle Aged, Prospective Studies, ROC Curve, Taiwan, Ventricular Dysfunction, Left, Risk Assessment, Asymptomatic Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review